An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit
Launched by FIRST AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIVERSITY · May 13, 2020
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. The patients who were diagnosed with NMOSD , and the cell-based assay was used to determine the AQP4-IgG-seropositive patients;
- • 2. AQP4-IgG is negative in health people with age and sex matching and determined by cell-based assay;
- • 3. Female or male, age 14-80;
- • 4. Patients or authorized family members volunteered to participate in this study and signed informed consent.
- Exclusion Criteria:
- • 1. Patients with coagulation disorders;
- • 2. Infection-related encephalitis;
- • 3. Immune-related encephalitis;
- • 4. A patient with severe mental illness who cannot cooperate clinically;
- • 5. A patient with severe jaundice.
About First Affiliated Hospital Of Fujian Medical University
The First Affiliated Hospital of Fujian Medical University is a leading medical institution dedicated to advancing healthcare through innovative clinical research and education. As a premier sponsor of clinical trials, the hospital is committed to improving patient outcomes and contributing to medical knowledge across various specialties. With a robust infrastructure and a multidisciplinary team of experienced researchers and healthcare professionals, the hospital ensures the ethical conduct and scientific rigor of its trials, fostering collaboration with global research communities. Its mission is to enhance the quality of care through evidence-based practices and to support the development of novel therapies that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, , China
Fuzhou, Fujian, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials